UA35689A - Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome - Google Patents

Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome

Info

Publication number
UA35689A
UA35689A UA97126410A UA97126410A UA35689A UA 35689 A UA35689 A UA 35689A UA 97126410 A UA97126410 A UA 97126410A UA 97126410 A UA97126410 A UA 97126410A UA 35689 A UA35689 A UA 35689A
Authority
UA
Ukraine
Prior art keywords
medicamentous
enteral
syndrome
patients
correction
Prior art date
Application number
UA97126410A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ігор Миколайович Дейкало
Игорь Николаевич Дейкало
Іван Іванович Чонка
Иван Иванович Чонка
Віктор Олександрович Шідловський
Виктор Александрович Шидловский
Original Assignee
Тернопільська державна медична академія ім. І.Я. Горбачевського
Тернопольская государственная медицинская академия им. И.Я. Горбачевского
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тернопільська державна медична академія ім. І.Я. Горбачевського, Тернопольская государственная медицинская академия им. И.Я. Горбачевского filed Critical Тернопільська державна медична академія ім. І.Я. Горбачевського
Priority to UA97126410A priority Critical patent/UA35689A/en
Publication of UA35689A publication Critical patent/UA35689A/en

Links

Abstract

The invention relates to the medicine. The method comprises the use of Phenobarbital for correcting the membrane hydrolysis and the preparations of Rhodiola rosea.
UA97126410A 1997-12-29 1997-12-29 Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome UA35689A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97126410A UA35689A (en) 1997-12-29 1997-12-29 Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97126410A UA35689A (en) 1997-12-29 1997-12-29 Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome

Publications (1)

Publication Number Publication Date
UA35689A true UA35689A (en) 2001-04-16

Family

ID=74181728

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97126410A UA35689A (en) 1997-12-29 1997-12-29 Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome

Country Status (1)

Country Link
UA (1) UA35689A (en)

Similar Documents

Publication Publication Date Title
CY1117668T1 (en) PHARMACEUTICAL RECOMMENDATIONS INCLUDING INSULIN CONTAINED WITH A DICETEPIPERAZINE
SE9702860L (en) Use of a strain of Lactobacillus for the manufacture of a drug for reducing fibrinogen content in blood
ATE401892T1 (en) USE OF PHARMACEUTICAL PREPARATIONS CONTAINING OXCARBAZEPINE IN THE FUTTING STATE
PL350658A1 (en) Medical preparations for the treatment of alpha−galactosidase a deficiency
TW200711657A (en) Pharmaceutical composition comprising botulinum toxin and recombinant human serum albumin
AU7315496A (en) Delivery of biologically active polypeptides
EP0859627A4 (en) Mimicking peptides in cancer therapy
ATE229335T1 (en) HETEROCYCLIC BIZYCLES FOR THE TREATMENT OF IMPOTENCY
HK15293A (en) Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
DE3763851D1 (en) SYSTEM FOR DISPOSAL OF MEDICINAL PRODUCTS WITH INCREASED BIO ACCEPTANCE.
MX9803610A (en) Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system.
EE04330B1 (en) Transmucosal formulations of levosimendan and their use in the manufacture of a medicament
UA35689A (en) Method for medicamentous correction of body function in patients with thyrotoxic goiter and enteral syndrome
AU5643299A (en) Humic acid and its use in the treatment of various conditions
DE50113974D1 (en) COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE SUBSTANCES
KR100488038B1 (en) New bpc peptide salts with organo-protective activity the process for their preparation and their use in therapy
SE9000207L (en) MEDICINAL PRODUCTS AND THE USE OF THE SAME
AU4300700A (en) Inactivated cytokines for immunisation
ES2128966A1 (en) Stable, tissue compatible, injectable calcitonin solutions
GR1002968B (en) Medicinal preparation based on fetal cell suspension having immunocorrecting effect and method of sugar diabetes treatment with the use of said preparation.
MD1135G2 (en) Paradontium treatment method
UA28462A (en) Drug with anti-inflammatory and reparative action
UA28511A (en) Method for detoxication of organism
MX9603241A (en) Pharmaceutical products to heal tumor diseases, and process for the preparation thereof.
MX9604539A (en) Modified amino acids for drug delivery.